SYMCREVO Trademark

Trademark Overview


On Friday, January 8, 2021, a trademark application was filed for SYMCREVO with the United States Patent and Trademark Office. The USPTO has given the SYMCREVO trademark a serial number of 79306163. The federal status of this trademark filing is REGISTERED as of Tuesday, August 24, 2021. This trademark is owned by Glaxo Group Limited. The SYMCREVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
symcrevo

General Information


Serial Number79306163
Word MarkSYMCREVO
Filing DateFriday, January 8, 2021
Status700 - REGISTERED
Status DateTuesday, August 24, 2021
Registration Number6458434
Registration DateTuesday, August 24, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, August 11, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, November 8, 2021NOTIFICATION PROCESSED BY IB
Wednesday, October 20, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 15, 2021FINAL DISPOSITION PROCESSED
Thursday, September 23, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, August 24, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2021NOTICE OF PUBLICATION
Wednesday, May 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 30, 2021ASSIGNED TO EXAMINER
Friday, March 19, 2021APPLICATION FILING RECEIPT MAILED
Monday, March 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 12, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB